Tri-linyah vs. Femcon fe: side effect and effectiveness comparison - a phase IV clinical study
We compare the side effects and drug effectiveness of Tri-linyah and Femcon fe. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 23,359 people who take Tri-linyah and Femcon fe, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
23,359 people who take Tri-linyah and Femcon fe are studied.
What is Tri-linyah?
Tri-linyah has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 71 Tri-linyah users for its effectiveness, alternative drugs and more.
What is Femcon fe?
Femcon fe has active ingredients of ethinyl estradiol; norethindrone. It is often used in birth control. eHealthMe is studying from 241 Femcon fe users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Femcon Fe (ethinyl estradiol; norethindrone)
- Tri-Linyah (ethinyl estradiol; norgestimate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
- not at all: 1.5 %
- somewhat: 6.24 %
- moderate: 10.91 %
- high: 32.1 %
- very high: 49.25 %
- not at all: 0.47000000000000003 %
- somewhat: 4.27 %
- moderate: 15.17 %
- high: 36.97 %
- very high: 43.13 %
Want to compare Tri-linyah with Femcon fe?Personalize this study to your gender and age (0-99+).
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of:
- Tri-linyah (63 reports)
- Femcon fe (175 reports)
How the study uses the data?
The study is based on ethinyl estradiol; norgestimate and ethinyl estradiol; norethindrone (the active ingredients of Tri-linyah and Femcon fe, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Doxycycline and Monoclonal Gammopathy - 46 seconds ago
- Seasonique and Amoxicillin drug interaction - a minute ago
- Motrin Ib and Osteoporosis - a minute ago
- Minipress and Osteoporosis - a minute ago
- Ms Contin and Osteoporosis - 2 minutes ago
- Mometasone Furoate and Osteoporosis - 2 minutes ago
- Atripla and Tinnitus - 3 minutes ago
- Cellcept and Oesophagitis Aggravated - 4 minutes ago
- Famotidine and Nitrous Oxide drug interaction - 4 minutes ago
- Gallbladder Cancer and Infection In An Immunocompromised Host - 4 minutes ago